Tumor mutational burden and response to programmed cell death protein 1 inhibitors in a case series of patients with metastatic desmoplastic melanoma.
- DOI
- 10.1016/j.jaad.2018.12.020
- Published
- 2019 Jun
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2018.12.020,
title = {Tumor mutational burden and response to programmed cell death protein 1 inhibitors in a case series of patients with metastatic desmoplastic melanoma.},
author = {Boussemart L and Johnson A and Schrock AB and Pal SK and Frampton GM and Fabrizio D and Chalmers Z and Lotem M and Gibney G and Russell J and Chmielowski B and Ross JS and Stephens PJ and Miller VA and Ali SM},
year = {2019},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2018.12.020},
url = {https://doi.org/10.1016/j.jaad.2018.12.020}
}RIS
TY - JOUR TI - Tumor mutational burden and response to programmed cell death protein 1 inhibitors in a case series of patients with metastatic desmoplastic melanoma. AU - Boussemart L AU - Johnson A AU - Schrock AB AU - Pal SK AU - Frampton GM AU - Fabrizio D AU - Chalmers Z AU - Lotem M AU - Gibney G AU - Russell J AU - Chmielowski B AU - Ross JS AU - Stephens PJ AU - Miller VA AU - Ali SM PY - 2019 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2018.12.020 UR - https://doi.org/10.1016/j.jaad.2018.12.020 ER -
APA
L, B., A, J., AB, S., SK, P., GM, F., D, F., Z, C., M, L., G, G., J, R., B, C., JS, R., PJ, S., VA, M., & SM, A. (2019). Tumor mutational burden and response to programmed cell death protein 1 inhibitors in a case series of patients with metastatic desmoplastic melanoma.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2018.12.020
Source records
- pubmed · retrieved 2026-09-25T01:08:10.673Z